Abeona Therapeutics Inc

NASDAQ:ABEO   4:00:00 PM EDT
7.34
-0.02 (-0.27%)
7:42:09 PM EDT: $7.53 +0.19 (+2.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)200.79M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.5 Million
Adjusted EPS-$0.57
See more estimates
10-Day MA$7.51
50-Day MA$6.52
200-Day MA$4.81
See more pivots

Abeona Therapeutics Inc Stock, NASDAQ:ABEO

6555 Carnegie Avenue, 4th floor, Cleveland, Ohio 44103
United States of America
Phone: +1.646.813.4701
Number of Employees: 84

Description

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.